Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0015876-67-2
Chemical Formula
C22-H32-Br2-N4-O4
Molecular Weight
576
Therapeutic Categories
Cholinesterase inhibitor (parasympathomimetic agent, indirect acting)
Treatment of myasthenia gravis
Drug acting on the gastrointestinal system
Urological
Chemical Name
Pyridinium, 3,3'-[1,6-hexanediylbis[(metylimino)carbonyl]oxy]bis[1-metyl-, dibromide
Foreign Names
- Distigmini Bromidum (Latin)
- Distigmin bromid (German)
- Bromure de Distigmine (French)
- Bromuro de distigmina (Spanish)
Generic Names
- Distigmine Bromide (OS: JAN, BAN)
- BC 51 (IS)
- Hexamarium Bromide (IS)
- Distigmine Bromide (PH: JP XVII)
Brand Names
- Adcostigmine
ADCO, Egypt - Distigmine Bromide
Takeda Teva Pharma, Japan - Ubretid
ADCO, Egypt; Eureco-Pharma, Netherlands; Euro Registratie, Netherlands; IFET, Greece; Medcor Pharmaceuticals, Netherlands; Nycomed, Egypt; Nycomed, Lebanon; Takeda, Czech Republic; Takeda, Hong Kong; Takeda, Poland; Takeda, Singapore; Takeda, Slovakia; Takeda Nederland, Netherlands; Torii Yakuhin, Japan - Ubretid 0,5mg
Takeda, Germany - Ubretid 0.5%
Torii Yakuhin, Japan - Ubretid 1%
Torii Yakuhin, Japan - Ubretid 5mg
Takeda, Germany; Takeda Pharma, Switzerland
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.